OOIR: Observatory of International Research

Papers

(The TQCC of Scandinavian Journal of Immunology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management	199
Pattern of human monocyte subpopulations in health and disease	112
Lymphopenia an important immunological abnormality in patients with COVID‐19: Possible mechanisms	75
T cell immunobiology and cytokine storm of COVID‐19	73
The TNF/IL‐23/IL‐17 axis—Head‐to‐head trials comparing different biologics in psoriasis treatment	57
An inflammation classification system using cytokine parameters	54
Mechanism of fibrosis and stricture formation in Crohn's disease	53
Advances in Neutralization Assays for SARS‐CoV‐2	41
Current knowledge on autoantigens and autoantibodies in psoriasis	40
Can medicinal mushrooms have prophylactic or therapeutic effect against COVID‐19 and its pneumonic superinfection and complicating inflammation?	37
Interactions between SARS coronavirus 2 papain‐like protease and immune system: A potential drug target for the treatment of COVID‐19	30
SARS‐CoV‐2 infection‐induced immune responses: Friends or foes?	30
The role of innate immunity and inflammation in Parkinson´s disease	28
TLR10: Insights, controversies and potential utility as a therapeutic target	27
Targeting regulatory T cells in anti‐PD‐1/PD‐L1 cancer immunotherapy	27
The potential involvement of P2X7 receptor in COVID‐19 pathogenesis: A new therapeutic target?	26
Cold‐inducible RNA‐binding protein (CIRP) in inflammatory diseases: Molecular insights of its associated signalling pathways	25
Immunodeficiency in cartilage‐hair hypoplasia: Pathogenesis, clinical course and management	24
Mucosal chemokine CXCL17: What is known and not known	24
Serum levels of soluble programmed death‐1 (sPD‐1) and soluble programmed death ligand 1(sPD‐L1) in systemic lupus erythematosus: Association with activity and severity	24
Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review	24
COVID‐19: Risk Factors Associated with Infectivity and Severity	23
Reviewing the importance of TLR‐NLRP3‐pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors	23
Overview of anti‐BCMA CAR‐T immunotherapy for multiple myeloma and relapsed/refractory multiple myeloma	23
The role of herpesvirus 6A and 6B in multiple sclerosis and epilepsy	22

Natural killer cell–derived extracellular vesicles in cancer therapy	21
The attentive focus on T cell‐mediated autoimmune pathogenesis of psoriasis, lichen planus and vitiligo	20
High CD4‐to‐CD8 ratio identifies an at‐risk population susceptible to lethal COVID‐19	20
B cell class switching in intestinal immunity in health and disease	20
Immunomodulatory potential of flavonoids for the treatment of autoimmune diseases and tumour	19
COVID‐19 immunopathology with emphasis on Th17 response and cell‐based immunomodulation therapy: Potential targets and challenges	19
The role of Interleukin‐32 in autoimmunity	19
Involvement of autophagy in MHC class I antigen presentation	18
Behçet disease (BD) and BD‐like clinical phenotypes: NF‐κB pathway in mucosal ulcerating diseases	18
Umbilical cord mesenchymal stem cells as well as their released exosomes suppress proliferation of activated PBMCs in multiple sclerosis	18
Are superantigens the cause of cytokine storm and viral sepsis in severe COVID‐19? Observations and hypothesis	18
COVID‐19 and maternal pre‐eclampsia: A synopsis	17
COVID‐19 and hepatic involvement: The liver as a main actor of the pandemic novel	16
Antibody combinations for optimized staining of macrophages in human lung tumours	16
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease	16
Immune surveillance in glioblastoma: Role of the NKG2D system and novel cell‐based therapeutic approaches	15
Protective roles for myeloid cells in neuroinflammation	15
Barley beta‐Glucan and Zymosan induce Dectin‐1 and Toll‐like receptor 2 co‐localization and anti‐leishmanial immune response in Leishmania donovani‐infected BALB/c mice	15
B cell helper T cells and type 1 diabetes	15
Features and roles of T helper 22 cells in immunological diseases and malignancies	15
Dual roles of granzyme B	14
IgG‐mediated suppression of antibody responses: Hiding or snatching epitopes?	14
T follicular regulatory cells: Guardians of the germinal centre?	14
Immunogenetics in systemic lupus erythematosus: Transitioning from genetic associations to cellular effects	14
A review of the immune response stimulated by xenogenic tissue heart valves	14
Genetic interaction between the non‐homologous end‐joining factors during B and T lymphocyte development: In vivo mouse models	14
Preoperative TruCulture® whole blood cytokine response predicts post‐operative inflammation in pancreaticoduodenectomy patients—A pilot cohort study	13
Immune checkpoint blockade and biomarkers of clinical response in non–small cell lung cancer	13
Cellular metabolism dictates T cell effector function in health and disease	13
Upregulated microRNA‐132 in T helper 17 cells activates hepatic stellate cells to promote hepatocellular carcinoma cell migration in vitro	12
Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab	12
Immunohistochemical characterization of immune cell infiltration in paediatric and adult Langerhans cell histiocytosis	12
The roles of small‐molecule inflammatory mediators in rheumatoid arthritis	12
Adipose‐derived mesenchymal stromal cells suppress osteoclastogenesis and bone erosion in collagen‐induced arthritis	12
Approaches to inducing antigen‐specific immune tolerance in allergy and autoimmunity: Focus on antigen‐presenting cells and extracellular vesicles	12
Increased expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and MMP10, MMP23 in inflammatory bowel disease: Cross‐sectional study	11
Consequences of maternal psychological stress during pregnancy for the risk of asthma in the offspring	11
T cell immunoglobulin and mucin domain protein 3 inhibits glycolysis in RAW 264.7 macrophages through Hexokinase 2	11
Long‐term in vitro persistence of magnetic properties after magnetic bead‐based cell separation of T cells	11
Expression of TOB/BTG family members in patients with inflammatory bowel disease	11
B cell signalling pathways—New targets for precision medicine in chronic lymphocytic leukaemia	11
Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases	11
Putative role of marginal zone B cells in pathophysiological processes	10
Spectrum of Inborn errors of immunity in a cohort of 90 patients presenting with complications to BCG vaccination in India	10
Adaptor proteins: Flexible and dynamic modulators of immune cell signalling	10
The immunomodulatory potentials of interleukin‐27 in airway allergies	10
Perforin, COVID‐19 and a possible pathogenic auto‐inflammatory feedback loop	10
Mast cell density in metastatic renal cell carcinoma: Association with prognosis and tumour‐infiltrating lymphocytes	10
An increase in CD62L^dim neutrophils precedes the development of pulmonary embolisms in COVID‐19 patients	10
Immunobiology and conflicting roles of the human CD161 receptor in T cells	9

Early humoral defence: Contributing to confining COVID‐19 to conducting airways?	9
Rational harm‐benefit assessments by age group are required for continued COVID‐19 vaccination	9
Differential diagnosis of primary immunodeficiency in patients with BCGitis and BCGosis: A single‐centre study	9
Toll‐like receptor‐2/7‐mediated T cell activation: An innate potential to augment CD8⁺ T cell cytokine production	9
Diagnostic and therapeutic caveats in Griscelli syndrome	9
Coronavirus infection: An immunologists' perspective	9
Immunoglobulin G complexes without sialic acids enhance osteoclastogenesis but do not affect arthritis‐mediated bone loss	9
Innate lymphoid cells in colorectal cancer	9
Serum‐soluble PD‐L1 may be a potential diagnostic biomarker in sepsis	9
Fungal recognition by mammalian fibrinogen‐related proteins	9
Profiling the pattern of human TRB/IGH‐CDR3 repertoire in liver transplantation patients via high‐throughput sequencing analysis	8
Insights into the toll‐like receptors in sexually transmitted infections	8
Prognostic value and predictive biomarkers of phenotypes of tumour‐associated macrophages in colorectal cancer	8
Role of the antigen presentation process in the immunization mechanism of the genetic vaccines against COVID‐19 and the need for biodistribution evaluations	8
Immunophenotypic and functional analysis of lymphocyte subsets in common variable immunodeficiency patients without monogenic defects	8
Functional immune reconstitution early after allogeneic haematopoietic cell transplantation: A comparison of pre‐ and post‐transplantation cytokine responses in stimulated whole blood	8
Macrophages and scavenger receptors in obesity‐associated non‐alcoholic liver fatty disease (NAFLD)	8
The pathogenesis of cutaneous lupus erythematosus: The aberrant distribution and function of different cell types in skin lesions	8
Gastrointestinal and renal complications in SARS‐CoV‐2‐infected patients: Role of immune system	8
IL‐6 alters migration capacity of CD4⁺Foxp3⁺ regulatory T cells in systemic lupus erythematosus	8
The role of the cholinergic anti‐inflammatory pathway in autoimmune rheumatic diseases	8
Correlation of myeloid‐derived suppressor cells with C‐reactive protein, ferritin and lactate dehydrogenase levels in patients with severe COVID‐19	8
Association of reduced maternal sHLA‐G5 isoform levels and elevated TNF‐α/IL‐4 cytokine ratio with Recurrent Pregnancy Loss: A study on South Indian women	7
Decreased neutrophil‐mediated bacterial killing in COVID‐19 patients	7
T cell receptor therapy against melanoma—Immunotherapy for the future?	7
Immune and stromal related genes in colon cancer: Analysis of tumour microenvironment based on the cancer genome atlas (TCGA) and gene expression omnibus (GEO) databases	7
Oromucosal immunomodulation as clinical spectrum mitigating factor in SARS‐CoV‐2 infection	7
Disease mechanisms in Sjögren’s syndrome: What do we know?	7
A review on the interactions between dendritic cells, filarial parasite and parasite‐derived molecules in regulating the host immune responses	7
Bioinformatics analysis of gene expression profiles of Inclusion body myositis	7
The role of cytokines in determining the Th1/Th2 phenotype of an immune response: Coherence of the T cell response and the Cytokine Implementation Hypothesis	7
An explanation of the pathogenesis of several autoimmune diseases in immuno‐compromised individuals	7
CX3CR1 might be a promising predictor of systemic lupus erythematosus patients with pulmonary fibrosis	7
The historical postulate: Is it the basis, at the level of the system, for self‐nonself discrimination?	7
Interleukin 4 deficiency limits the development of a lupus‐like disease in mice triggered by phospholipids in a non‐bilayer arrangement	7
Upregulation of the expression of Toll‐like receptor 9 in basophils in patients with allergic rhinitis: An enhanced expression by allergens	6
The effect of BCG vaccine in the era of COVID‐19 pandemic	6
The immune microenvironment in typical carcinoid lung tumour, a brief report of four cases	6
Severe COVID‐19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils	6
Gut tissue‐resident memory T cells in coeliac disease	6
The neonatal Fc receptor in mucosal immune regulation	6
Lipopolysaccharide‐responsive beige‐like anchor acts as a cAMP‐dependent protein kinase anchoring protein in B cells	6
Physiological levels of 25‐hydroxyvitamin D₃ induce a suppressive CD4⁺ T cell phenotype not reflected in the epigenetic landscape	6
Zinc homeostasis in immunity and its association with preterm births	6
Myeloid‐derived suppressor cells: Bridging the gap between inflammation and pancreatic adenocarcinoma	6
Chrysin enhances antitumour immunity response through the IL‐12‐STAT4 signal pathway in the B16F10 melanoma mouse model	6
Advances in CD247	6
Saturated fatty acids activate the inflammatory signalling pathway in Schwann cells: Implication in sciatic nerve injury	6
Can interruption/withdrawl of anti‐retroviral therapy provide personalized immunotherapy against HIV‐1?	6
SJI 2020 special issue: A catalogue of Ovarian Cancer targets for CAR therapy	6
IL‐16 processing in sentinel node regulatory T cells is a factor in bladder cancer immunity	6
Aicardi–Goutières syndrome: A monogenic type I interferonopathy	6
The cytokine storm—An appropriate, over‐reactive response to SARS‐CoV‐2 or the wrong immune pathway?	6
Interferons and innate immune activation in autoimmune congenital heart block	6
Microbial sensing by haematopoietic stem and progenitor cells: Vigilance against infections and immune education of myeloid cells	6
Non‐tuberculous mycobacteria immunopathogenesis: Closer than they appear. a prime of innate immunity trade‐off and NTM ways into virulence	6